Combining biopsy tools improves mutation detection rate in central lung cancer.
Lars HagmeyerStephan SchäferMarianne EngelsJana FassunkeAnja Pietzke-CalcagnileMarcel TremlSimon-Dominik HerkenrathSandhya MatthesJürgen WolfReinhard BüttnerWinfried RanderathPublished in: ERJ open research (2020)
In central exophytic lung cancer, the detection rate of oncogenic mutations and PDL1 positivity may be increased by combined sampling by forceps and EBUS-TBNA. The additional sampling of mediastinal lymph node and ctDNA may not be of additional benefit. https://bit.ly/2Ve41EF.